Insider · CIK 0001692506

DiFabio Andrea

Reports to the SEC for 2 companies · BURNABY, A1

sec.gov

Transactions

Companies

Filings

CIK

0001692506

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-13	XENEXenon Pharmaceuticals Inc.S Sale	Chief Legal Officer	SSale	−1,342 sh	$55.23	−$74.1K	7,301
2026-03-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,750 sh	—	—	8,643
2026-03-12	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,750 sh	—	—	11,250
2026-03-10	XENEXenon Pharmaceuticals Inc.S Sale	Chief Legal Officer	SSale	−2,607 sh	$60.11	−$157K	4,893
2026-03-09	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+7,500 sh	—	—	7,500
2026-03-09	XENEXenon Pharmaceuticals Inc. · Performance Share UnitsA Award	Chief Legal Officer	AAward	+7,500 sh	—	—	7,500
2026-03-09	XENEXenon Pharmaceuticals Inc. · Performance Share UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−7,500 sh	—	—	0
2026-01-09	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Chief Legal Officer	AAward	+80K sh	—	—	80,000
2026-01-09	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Chief Legal Officer	AAward	+15K sh	—	—	15,000
2025-03-12	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Chief Legal Officer	AAward	+80K sh	—	—	80,000
2025-03-12	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Chief Legal Officer	AAward	+15K sh	—	—	15,000
2024-03-11	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+100K sh	—	—	100,000
2023-03-10	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+45K sh	—	—	45,000
2022-11-07	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+135K sh	—	—	135,000
2018-03-08	Bioverativ Inc.D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−30.6K sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−7,489 sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−31.8K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−29.8K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−59.6K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−29.8K sh	—	—	0
2018-02-23	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−917 sh	$104.74	−$96K	30,410.558
2018-02-22	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−2,011 sh	$104.30	−$210K	31,327.558
2018-02-14	Bioverativ Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+3,744 sh	—	—	34,474.558
2018-02-14	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,136 sh	$103.52	−$118K	33,338.558
2018-02-14	Bioverativ Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−3,744 sh	—	—	7,489
2018-01-31	Bioverativ Inc.Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+31.8K sh	—	—	31,818
2017-11-02	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−636 sh	$53.65	−$34.1K	30,730.558
2017-02-28	Bioverativ Inc.A Award	EVP, Chief Legal Officer	AAward	+35K sh	—	—	35,985
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,155 sh	$43.42	−$50.2K	34,830
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−368 sh	$49.56	−$18.2K	34,462
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,191 sh	$47.76	−$56.9K	33,271
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−532 sh	$43.42	−$23.1K	32,739
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−285 sh	$49.56	−$14.1K	32,454
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−918 sh	$47.76	−$43.8K	31,536
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−718 sh	$43.42	−$31.2K	30,818
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, Chief Legal Officer	AAward	+29.8K sh	—	—	29,797
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, Chief Legal Officer	AAward	+59.6K sh	—	—	59,595
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, Chief Legal Officer	AAward	+29.8K sh	—	—	29,797
2017-02-14	Bioverativ Inc.Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+11.2K sh	—	—	11,233
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, Chief Legal Officer	AAward	+29.7K sh	—	—	29,744
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, Chief Legal Officer	AAward	+59.5K sh	—	—	59,488
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, Chief Legal Officer	AAward	+29.7K sh	—	—	29,744

Recent filings

Accepted (ET)
Mar 134
DiFabio Andrea0001193125-26-106726
SEC(opens sec.gov)
Mar 114
DiFabio Andrea0001193125-26-102667
SEC(opens sec.gov)
Jan 94
DiFabio Andrea0001193125-26-009232
SEC(opens sec.gov)
Mar 134
DiFabio Andrea0000950170-25-039020
SEC(opens sec.gov)
Mar 124
DiFabio Andrea0000950170-24-030228
SEC(opens sec.gov)
Mar 144
DiFabio Andrea0001209191-23-018501
SEC(opens sec.gov)
Nov 94
DiFabio Andrea0001209191-22-056248
SEC(opens sec.gov)
Mar 84
DiFabio Andrea0001127602-18-010654
SEC(opens sec.gov)

Companies

Address

3650 GILMORE WAY

BURNABY, A1, V5G 4W8